(Q33349424)

English

The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel (English)

1 reference

Europe PubMed Central

26 July 2017

quality of life

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Thomas A Hensing

1

1 reference

Europe PubMed Central

26 July 2017

Amy H Peterman

2

1 reference

Europe PubMed Central

26 July 2017

Michael J Schell

3

1 reference

Europe PubMed Central

26 July 2017

Ji-Hyun Lee

4

1 reference

Europe PubMed Central

26 July 2017

Mark A Socinski

5

1 reference

Europe PubMed Central

26 July 2017

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

26 July 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

26 July 2017

98

1 reference

Europe PubMed Central

26 July 2017

4

1 reference

Europe PubMed Central

26 July 2017

779-788

1 reference

Europe PubMed Central

26 July 2017

Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11548

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of patterns of care of nonsmall cell lung carcinoma patients in a younger and Medigap commercially insured cohort

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11548

7 January 2021

based on heuristic

inferred from DOI database lookup

Who gets chemotherapy for metastatic lung cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11548

7 January 2021

based on heuristic

inferred from DOI database lookup

Differences in initial treatment patterns and outcomes of lung cancer in the elderly.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11548

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical aspects of cancer in the elderly. Treatment decisions, treatment choices, and follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11548

7 January 2021

based on heuristic

inferred from DOI database lookup

Underrepresentation of patients 65 years of age or older in cancer-treatment trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11548

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of cancer in the older person: a practical approach

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11548

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11548

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11548

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11548

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11548

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns of practice survey for nonsmall cell lung carcinoma in the U.S.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11548

7 January 2021

based on heuristic

inferred from DOI database lookup

Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11548

7 January 2021

based on heuristic

inferred from DOI database lookup

The ELVIS trial: a phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Elderly Lung Cancer Vinorelbine Italian Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11548

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11548

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin-based combination chemotherapy for elderly patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11548

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ functions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11548

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical benefit from palliative chemotherapy in non-small-cell lung cancer extends to the elderly and those with poor prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11548

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11548

7 January 2021

based on heuristic

inferred from DOI database lookup

Retrospective comparison of toxicity and efficacy in phase II trials of 3-h infusions of paclitaxel for patients 70 years of age or older and patients under 70 years of age

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11548

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.11548

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33349424&oldid=1773391750"